Goodluck India Limited (GOODLUCK)
Outcome of Board Meeting
Press Release - Q2FY27
- Consolidated revenue 13.74bn +38% y-y; EBITDA 1.27bn +31% y-y; PAT 507mn +19% y-y
- Volume growth of 18% driven by higher sales of value-added products in Q2 FY27
- Export revenue grew ~38% YoY, contributing ~28% of total revenue in H1 FY27
- Defence order production in initial trial phase; revenue expected later in FY27
- Board approved corporate restructuring to amalgamate subsidiaries for integrated structure
- Completed 2:1 bonus issue increasing paid-up capital to 199.4mn shares
- Outlook: Focus on volume growth, operating efficiencies, product mix, and capacity utilization
- Defence business offers long-term diversification; technical qualification for artillery shells
- Corporate consolidation aims to align businesses for strategic and operational efficiency
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GOODLUCK — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GOODLUCK to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Goodluck India Limited
Important.
The summary above is generated automatically from Goodluck India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.